Thomas P. Grace, Andrew Edgington, Laura Reinhart, Timothy Burkart, Elisa Dyer, Jessica Halsey, Karim Baroudi, Christian Hicks, Jennifer E. Layne, Tomas C. Walker
{"title":"The Dexcom Community Glucose Monitoring Project: Six-Month Results Using Continuous Glucose Monitoring in Type 2 Diabetes","authors":"Thomas P. Grace, Andrew Edgington, Laura Reinhart, Timothy Burkart, Elisa Dyer, Jessica Halsey, Karim Baroudi, Christian Hicks, Jennifer E. Layne, Tomas C. Walker","doi":"10.2337/cd24-0030","DOIUrl":null,"url":null,"abstract":"The Dexcom Community Glucose Monitoring Project is a collaborative, ongoing, primary care–driven public health initiative designed to provide continuous glucose monitoring (CGM) systems to adults with type 2 diabetes who lack health insurance coverage for CGM. After 6 months of program participation, mean A1C decreased by 2.4 ± 1.9% from baseline to 6-month follow-up (from 9.4 ± 1.7 to 7.1 ± 1.2%, P <0.001). There was a clinically meaningful and statistically significant improvement in CGM metrics as well. Greater CGM use in the primary care setting among people with type 2 diabetes may help patients successfully manage their diabetes.","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":"47 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd24-0030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The Dexcom Community Glucose Monitoring Project is a collaborative, ongoing, primary care–driven public health initiative designed to provide continuous glucose monitoring (CGM) systems to adults with type 2 diabetes who lack health insurance coverage for CGM. After 6 months of program participation, mean A1C decreased by 2.4 ± 1.9% from baseline to 6-month follow-up (from 9.4 ± 1.7 to 7.1 ± 1.2%, P <0.001). There was a clinically meaningful and statistically significant improvement in CGM metrics as well. Greater CGM use in the primary care setting among people with type 2 diabetes may help patients successfully manage their diabetes.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
